Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures

http://www.psychicsdirectory.co.uk/index.php?s=D&c=486
Any determinations regarding the convertibility of the Debenturee during future periods will be made in accordance with the termss of the indenture under whic the Debentures wereissued (the "Indenture"). The Debenturex became convertible because the last reported sale price of Allscripts common stock for at least 20 consecutivwe trading days withinthe 30-trading-day perioc ending on May 29, 2009 was greater than 130 percen t of the conversion price in effect on May 29, 2009.
As a during the conversion period, holders of the Debenturesw may convert the Debentures into sharesd ofcommon stock, subject to the terms of the Pursuant to the terms of the Indenture, the Debenture are convertible at the conversiojn rate of 124.3781 shares per $1,0009 principal amount of each Debenture. Allscripts has the rightt to satisfy the conversion with cash in lieu of sharez of common stock in accordancde with the terms ofthe Indenture.
Allscripts announced today that, pursuanyt to the terms of the Indenture, holdersz of Debentures have the right to requirs Allscripts to repurchase their Debentures (the "Repurchase Right") for cash in an amountf equal to 100 percent of the principal amount of the Debentures ($1,000 per each $1,000 principal amoun outstanding) plus accrued and unpaid interest and Liquidated Damagess (as defined in the Indenture) to, but excluding, July 15, 2009. The Repurchaser Right is subject to the terms and conditions described in the Noticw of Right to Requirr Repurchase sent to Debenture holders andthe Indenture. The Repurchasse Right will expireat 5:00 p.m., Eastern Daylight on July 15, 2009.
In order to surrender Debenturefor purchase, a purchased notice must be delivered to Wilmington Trust FSB, as successo trustee and paying agent to LaSallre Bank N.A., or through The Depository Trusy Company by 5:00 p.m., Eastern Daylight Time, on July 15, 2009. Holders may withdraw any Debentures previouslyu surrendered for purchase at any time prioeto 5:00 p.m., Eastern Daylight on July 15, 2009 by deliverinhg a notice of withdrawal to the paying agent at the address listed in the Notice of Right to Requirse Repurchase or through the Depository Trust Debenture holders are urged to consulyt their tax advisor regarding the tax consequencex of the foregoing.
Allscripts MDRX) uses innovation technology to bring healthto healthcare. More than 150,000o physicians, 700 hospitals and nearly 7,00p0 post-acute and homecare organizations utilize Allscripts to improve the healtjh of their patients and theirbottom line. The company'es award-winning solutions include electronichealth records, electronivc prescribing, revenue cycle management, practice document management, medication services, hospital care management, emergency departmengt information systems and homecare automation. Allscripts is the brande name of Allscripts-Misys Healthcare Solutions, Inc. To learnj more, visit .
This news releasee may contain forward-looking statements within the meaningv of the federalsecuritiews laws. Statements regarding future events, developments, the Company'z future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relatinyg to the futureare forward-looking statement within the meaning of these laws. Theswe forward-looking statements are subject to a number of risks and some of which are outlined Asa result, actualo results may vary materially from thoses anticipated by the forward-looking statements.
Amonvg the important factors that could cause actual resulte to differ materially from thosre indicated bysuch forward-looking statements are: the volumd and timing of systems sales and installations; lengtbh of sales cycles and the installatiobn process; the possibility that products will not achievew or sustain market acceptance; the cost and success or failurs of new product and service introductions, development and produc t upgrade releases; competitive pressures including productg offerings, pricing and promotional activities; our abilith to establish and maintain strategi c relationships; undetected errors or similar problemss in our software products; compliance with existing laws, regulations and industru initiatives and future changess in laws or regulations in the healthcare possible regulation of the Company's software by the U.
S. Food and Drug the possibilityof product-related liabilities; our ability to attracy and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integratw acquisitions; the ability to recognize the benefits of the mergeer with Misys Healthcare Systems, LLC ("MHS"); the integratio n of MHS with the Company and the possibls disruption of current plans and operationxs as a result thereof; maintainingy our intellectual property rights and litigation involvinyg intellectual property rights; risks related to third-party our ability to obtain, use or successfully integrate third-party licensed technology; breacyh of our security by third parties; and the risk factorsx detailed from time to time in our reports filesd with the Securities and Exchange including our 2007 Annual Report on Form 10-K available through the Web site maintaineed by the Securities and Exchange Commissioj at .
The Company undertakea no obligation to update publiclyany forward-looking whether as a resul of new information, future events or otherwise.